Personensuche
Personensuche
Es wurde 1 Person gefunden.
Funktionen
-
---, Klinik für Frauenheilkunde und Geburtshilfe
Aktuelle Veranstaltungen
Vergangene Veranstaltungen (max. 10)
-
WiSe 2024
-
SoSe 2024
-
WiSe 2023
-
SoSe 2023
-
WiSe 2022
-
SoSe 2022
-
WiSe 2021
-
SoSe 2021
-
WiSe 2020
-
SoSe 2020
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Gene expression analysis in circulating tumour cells to determine resistance to CDK4/6 inhibitors plus endocrine therapy in HR + /HER2- metastatic breast cancer patientsIn: Journal of Translational Medicine , Jg. 23 2025 , Nr. 1 , 400DOI (Open Access)
-
Thymidine kinase 1 concentration and activity in metastatic breast cancer under CDK4/6 inhibitor therapyIn: Scientific Reports , Jg. 15 2025 , Nr. 1 , 10347DOI (Open Access)
-
High serum levels of leucine-rich α-2 glycoprotein 1 (LRG-1) are associated with poor survival in patients with early breast cancerIn: Archives of Gynecology and Obstetrics , Jg. 309 2024 , Nr. 6 , S. 2789 - 2798DOI (Open Access)
-
Correlation between Imaging Markers Derived from PET/MRI and Invasive Acquired Biomarkers in Newly Diagnosed Breast CancerIn: Cancers , Jg. 15 2023 , Nr. 6 , 1651DOI (Open Access)
-
Elevated sHLA-G plasma levels post chemotherapy combined with ILT-2 rs10416697C allele status of the sHLA-G-related receptor predict poorest disease outcome in early triple-negative breast cancer patientsIn: Frontiers in Immunology , Jg. 14 2023 , 1188030DOI, Online Volltext (Open Access)
-
Programmed death receptor ligand-2 (PD-L2) bearing extracellular vesicles as a new biomarker to identify early triple-negative breast cancer patients at high risk for relapseIn: Journal of Cancer Research and Clinical Oncology , Jg. 149 2023 , Nr. 3 , S. 1159 - 1174DOI (Open Access)
-
Ratios of monocytes and neutrophils to lymphocytes in the blood predict benefit of CDK4/6 inhibitor treatment in metastatic breast cancerIn: Scientific Reports , Jg. 13 2023 , Nr. 1 , 21262DOI, Online Volltext (Open Access)
-
The Diversity of Liquid Biopsies and Their Potential in Breast Cancer ManagementIn: Cancers , Jg. 15 2023 , Nr. 22 , 5463DOI (Open Access)
-
Combinatorial Power of cfDNA, CTCs and EVs in OncologyIn: Diagnostics , Jg. 12 2022 , Nr. 4 , S. 870DOI, Online Volltext (Open Access)
-
Detection of ESR1 Mutations in Primary Tumors and Plasma Cell-Free DNA in High-Grade Serous Ovarian Carcinoma PatientsIn: Cancers , Jg. 14 2022 , Nr. 15 , 3790DOI (Open Access)
-
In Early Breast Cancer, the Ratios of Neutrophils, Platelets and Monocytes to Lymphocytes Significantly Correlate with the Presence of Subsets of Circulating Tumor Cells but Not with Disseminated Tumor CellsIn: Cancers , Jg. 14 2022 , Nr. 14 , 3299DOI, Online Volltext (Open Access)
-
Multimodality in liquid biopsy : does a combination uncover insights undetectable in individual blood analytes?In: Journal of Laboratory Medicine , Jg. 46 2022 , Nr. 4 , S. 255 - 264DOI (Open Access)
-
Prognostic significance of SLFN11 methylation in plasma cell-free dna in advanced high-grade serous ovarian cancerIn: Cancers , Jg. 14 2022 , Nr. 1 , 4DOI (Open Access)
-
Single HER2-positive tumor cells are detected in initially HER2-negative breast carcinomas using the DEPArray™–HER2-FISH workflowIn: Breast Cancer: The Journal of the Japanese Breast Cancer Society , Jg. 29 2022 , Nr. 3 , S. 487 - 497DOI (Open Access)
-
Systematic Evaluation of HLA-G 3’Untranslated Region Variants in Locally Advanced, Non-Metastatic Breast Cancer Patients : UTR-1, 2 or UTR-4 are Predictors for Therapy and Disease OutcomeIn: Frontiers in Immunology , Jg. 12 2022 , 817132DOI, Online Volltext (Open Access)
-
An observational study on breast cancer survival and lifestyle related risk factorsIn: In Vivo , Jg. 35 2021 , Nr. 2 , S. 1007 - 1015DOI (Open Access)
-
Association of Soluble B7-H4 and Circulating Tumor Cells in Blood of Advanced Epithelial Ovarian Cancer PatientsIn: Frontiers in Oncology , Jg. 11 2021 , 721067DOI, Online Volltext (Open Access)
-
Disseminated tumour cells from the bone marrow of early breast cancer patients : Results from an international pooled analysisIn: European Journal of Cancer (EJC) , Jg. 154 2021 , S. 128 - 137
-
Image-based identification and genomic analysis of single circulating tumor cells in high grade serous ovarian cancer patientsIn: Cancers , Jg. 13 2021 , Nr. 15 , 3748DOI, Online Volltext (Open Access)
-
Integrative statistical analyses of multiple liquid biopsy analytes in metastatic breast cancerIn: Genome Medicine , Jg. 13 2021 , Nr. 1 , 85DOI, Online Volltext (Open Access)
-
Longitudinal Multi-Parametric Liquid Biopsy Approach Identifies Unique Features of Circulating Tumor Cell, Extracellular Vesicle, and Cell-Free DNA Characterization for Disease Monitoring in Metastatic Breast Cancer PatientsIn: Cells , Jg. 10 2021 , Nr. 2 , S. 212DOI (Open Access)
-
Soluble Neuropilin-1 is an independent marker of poor prognosis in early breast cancerIn: Journal of Cancer Research and Clinical Oncology , Jg. 147 2021 , Nr. 8 , S. 2233 - 2238DOI (Open Access)
-
6-Color/1-Target Immuno-SERS Microscopy on the Same Single Cancer CellIn: ACS Applied Materials & Interfaces , Jg. 12 2020 , Nr. 29 , S. 32321 - 32327DOI (Open Access)
-
A proposal for score assignment to characterize biological processes from mass spectral analysis of serumIn: Clinical Mass Spectrometry , Jg. 18 2020 , S. 13 - 26DOI (Open Access)
-
CXCR4 and JUNB double-positive disseminated tumor cells are detected frequently in breast cancer patients at primary diagnosisIn: Therapeutic Advances in Medical Oncology , Jg. 12 2020DOI (Open Access)
-
Circulating Tumor Cells Expressing the Prostate Specific Membrane Antigen (PSMA) Indicate Worse Outcome in Primary, Non-Metastatic Triple-Negative Breast CancerIn: Frontiers in Oncology , Jg. 10 2020 , S. 1658DOI, Online Volltext (Open Access)
-
Circulating tumor cells expressing the prostate specific membrane antigen PSMA indicate worse outcome in triple-negative breast cancer patients at primary diagnosisIn: Cancer Research , Jg. 80 2020 , Nr. 4
-
Definition and independent validation of a proteomic-classifier in ovarian cancerIn: Cancers , Jg. 12 2020 , Nr. 9 , S. 2519DOI (Open Access)
-
High serum levels of periostin are associated with a poor survival in breast cancerIn: Breast Cancer Research and Treatment , Jg. 180 2020 , Nr. 2 , S. 515 - 524
-
Liquid Biopsies to Evaluate Immunogenicity of Gynecological/Breast Tumors : On the Way to Blood-Based Biomarkers for ImmunotherapiesIn: Breast Care , Jg. 15 2020 , Nr. 5 , S. 470 - 480DOI (Open Access)
-
Localization of PD-L1 on single cancer cells by iSERS microscopy with Au/Au core/satellite nanoparticlesIn: Journal of Biophotonics , Jg. 13 2020 , Nr. 3 , e201960034DOI (Open Access)
-
Molecular characterization of circulating tumour cells identifies predictive markers for outcome in primary, triple-negative breast cancer patientsIn: Journal of Cellular and Molecular Medicine , Jg. 24 2020 , Nr. 15 , S. 8405 - 8416DOI, Online Volltext (Open Access)
-
Multimodal targeted deep sequencing of circulating tumor cells and matched cell-free DNA provides a more comprehensive tool to identify therapeutic targets in metastatic breast cancer patientsIn: Cancers , Jg. 12 2020 , Nr. 5DOI, Online Volltext (Open Access)
-
Targeted deep sequencing revealed variants in cell-free DNA of hormone receptor-positive metastatic breast cancer patientsIn: Cellular and Molecular Life Sciences - CMLS , Jg. 77 2020 , Nr. 3 , S. 497 - 509DOI (Open Access)
-
The combined blood analysis of cell-free DNA and genomic DNA of circulating tumor cells reveals additive value in hormone receptor-positive, HER2-negative metastatic breast cancer patientsIn: Cancer Research , Jg. 80 2020 , Nr. 4
-
Cell-Free DNA Variant Sequencing Using CTC-Depleted Blood for Comprehensive Liquid Biopsy Testing in Metastatic Breast CancerIn: Cancers , Jg. 11 2019 , Nr. 2 , S. 238DOI, Online Volltext (Open Access)
-
Development and Validation of Multiplex Liquid Bead Array Assay for the Simultaneous Expression of 14 Genes in Circulating Tumor CellsIn: Analytical Chemistry , Jg. 91 2019 , Nr. 5 , S. 3443 - 3451
-
Digital immune-related gene expression signatures in high-grade serous ovarian carcinoma : Developing prediction models for platinum responseIn: Cancer Management and Research , Jg. 11 2019 , S. 9571 - 9583DOI, Online Volltext (Open Access)
-
Dissimilar patterns of tumor-infiltrating immune cells at the invasive tumor front and tumor center are associated with response to neoadjuvant chemotherapy in primary breast cancerIn: BMC Cancer , Jg. 19 2019 , Nr. 1 , S. 120DOI (Open Access)
-
Extracellular vesicle-associated miRNAs in ovarian cancer - design of an integrated NGS-based workflow for the identification of blood-based biomarkers for platinum-resistanceIn: Clinical Chemistry and Laboratory Medicine , Jg. 57 2019 , Nr. 7 , S. 1053 - 1062
-
HLA-G 3′ untranslated region variants +3187G/G, +3196G/G and +3035T define diametrical clinical status and disease outcome in epithelial ovarian cancerIn: Scientific Reports , Jg. 9 2019 , Nr. 1 , S. 5407DOI, Online Volltext (Open Access)
-
High circulating levels of Periostin are associated with a poor survival in primary, non-metastatic breast cancer patientsIn: Cancer Research , Jg. 79 2019 , Nr. Suppl. 4
-
In primary, non-metastatic breast cancer patients, increased serum levels of RANKL significantly correlate with tumor cell spread to the bone and the occurrence of bone metastasis whereas high levels of its soluble decoy receptor osteoprotegerin predict poor survivalIn: Cancer Research , Jg. 79 2019 , Nr. Suppl. 4
-
International pooled analysis of the prognostic impact of disseminated tumor cells from the bone marrow in early breast cancer : Results from the PADDY studyIn: Cancer Research , Jg. 79 2019 , Nr. Suppl. 4
-
Liquid biopsy in ovarian cancer : the potential of circulating miRNAs and exosomesIn: Translational Research , Jg. 205 2019 , S. 77 - 91
-
Prognostic significance of PD-1 and PD-L1 positive tumor-infiltrating immune cells in ovarian carcinomaIn: International Journal of Gynecological Cancer , Jg. 29 2019 , Nr. 9 , S. 1389 - 1395
-
Prognostic value of RANKL/OPG serum levels and disseminated tumor cells in nonmetastatic breast cancerIn: Clinical Cancer Research , Jg. 25 2019 , Nr. 4 , S. 1369 - 1378DOI (Open Access)
-
Soluble Programmed Death Receptor Ligands sPD-L1 and sPD-L2 as Liquid Biopsy Markers for Prognosis and Platinum Response in Epithelial Ovarian CancerIn: Frontiers in Oncology , Jg. 9 2019DOI (Open Access)
-
The analysis of cell-free DNA and circulating tumor cells from one blood tube might empower treatment decisions in metastatic breast cancer patientsIn: Cancer Research , Jg. 79 2019 , Nr. Suppl. 4
-
The prognostic relevance of urokinase-type plasminogen activator (uPA) in the blood of patients with metastatic breast cancerIn: Scientific Reports , Jg. 9 2019 , Nr. 1 , S. 2318DOI (Open Access)
-
Vesicular-Bound HLA-G as a Predictive Marker for Disease Progression in Epithelial Ovarian CancerIn: Cancers , Jg. 11 2019 , Nr. 8 , S. 1106DOI (Open Access)
-
Zirkulierende Tumorzellen und was sie beinhalten : Sind »Liquid Biopsies« die Zukunft?In: Chirurgische Praxis , Jg. 86 2019 , Nr. 1 , S. 125 - 134
-
ESR1 methylation in primary tumors and paired circulating tumor DNA of patients with high-grade serous ovarian cancerIn: Gynecologic Oncology , Jg. 150 2018 , Nr. 2 , S. 355 - 360
-
Elevated levels of extracellular vesicles are associated with therapy failure and disease progression in breast cancer patients undergoing neoadjuvant chemotherapyIn: OncoImmunology , Jg. 7 2018 , Nr. 1 , e1376153DOI (Open Access)
-
Elevated serum RAS p21 is an independent prognostic factor in metastatic breast cancerIn: BMC Cancer , Jg. 18 2018 , S. 541DOI (Open Access)
-
Liquid biopsy in ovarian cancer : Recent advances on circulating tumor cells and circulating tumor DNAIn: Clinical Chemistry and Laboratory Medicine , Jg. 56 2018 , Nr. 2 , S. 186 - 197DOI (Open Access)
-
RNA profiles of circulating tumor cells and extracellular vesicles for therapy stratification of metastatic breast cancer patientsIn: Clinical Chemistry , Jg. 64 2018 , Nr. 7 , S. 1054 - 1062
-
The association of soluble HLA-G levels and 3 untranslated region haplotypes of the HLA-G gene with the clinical profile of epithelial ovarian cancer patients regarding disease stage, circulating tumor cells and overall survivalIn: HLA: Immune Response Genetics (Human Leukocyte Antigens) , Jg. 91 2018 , Nr. 5 , S. 467 - 467
-
The clinical relevance of serum vascular endothelial growth factor (VEGF) in correlation to circulating tumor cells and other serum biomarkers in patients with metastatic breast cancerIn: Breast Cancer Research and Treatment , Jg. 172 2018 , Nr. 1 , S. 93 - 104
-
Zirkulierende Tumorzellen und was sie beinhalten : Sind »Liquid Biopsies« die Zukunft?In: Pädiatrische Praxis , Jg. 91 2018 , Nr. 1 , S. 15 - 24
-
Zirkulierende Tumorzellen und was sie beinhalten : Sind »Liquid Biopsies« die Zukunft?In: Gynäkologische Praxis , Jg. 44 2018 , Nr. 1 , S. 75 - 84
-
Circulating tumor cells in triple-negative breast cancer patients express prostate related genes and show different genetic profiles in US and German patient cohortsIn: Cancer Research , Jg. 77 2017 , Nr. 4
-
Clinical relevance of serum HER2 and circulating tumor cell detection in metastatic breast cancer patientsIn: Anticancer Research , Jg. 37 2017 , Nr. 6 , S. 3117 - 3128
-
Comparison of HER2, estrogen and progesterone receptor expression profiles of primary tumor, synchronous axillary lymph node metastases and circulating tumor cells in early breast cancer patientsIn: Cancer Research , Jg. 77 2017 , Nr. 4 , S. P1 - 01
-
Comparison of the PI3KCA pathway in circulating tumor cells and corresponding tumor tissue of patients with metastatic breast cancerIn: Molecular Medicine Reports , Jg. 15 2017 , Nr. 5 , S. 2957 - 2968DOI (Open Access)
-
Development of a novel HER2 testing strategy, using image-based cell-sorting to isolate pure cell populations from FFPE upstream of FISHIn: Cancer Research , Jg. 77 2017 , Nr. 4 , S. P5 - 03
-
EMT-like circulating tumor cells in ovarian cancer patients are enriched by platinum-based chemotherapyIn: OncoTarget , Jg. 8 2017 , Nr. 30 , S. 48820 - 48831DOI (Open Access)
-
ERCC1-expressing circulating tumor cells as a potential diagnostic tool for monitoring response to platinum-based chemotherapy and for predicting post-therapeutic outcome of ovarian cancerIn: OncoTarget , Jg. 8 2017 , Nr. 15 , S. 24303 - 24313DOI (Open Access)
-
Evaluation of serum epidermal growth factor receptor (EGFR) in correlation to circulating tumor cells in patients with metastatic breast cancer.In: Scientific Reports , Jg. 7 2017 , Nr. 1 , S. 17307DOI (Open Access)
-
Fast and reproducible iSERS microscopy of single HER2-positive breast cancer cells using gold nanostars as SERS nanotags.In: Faraday Discussions , Jg. 2015 2017 , S. 377 - 386
-
Gene expression signatures in circulating tumor cells correlate with response to therapy in metastatic breast cancerIn: Clinical Chemistry , Jg. 63 2017 , Nr. 10 , S. 1585 - 1593
-
RASSF1A promoter methylation in high-grade serous ovarian cancer : A direct comparison study in primary tumors, adjacent morphologically tumor cell-free tissues and paired circulating tumor DNAIn: OncoTarget , Jg. 8 2017 , Nr. 13 , S. 21429 - 21443DOI (Open Access)
-
Serum levels of RANKL are increased in primary breast cancer patients in the presence of disseminated tumor cells in the bone marrowIn: Cancer Research , Jg. 77 2017 , Nr. 4
-
Therapeutic antibody targeting tumor- and osteoblastic niche-derived jagged1 sensitizes bone metastasis to chemotherapyIn: Cancer Cell , Jg. 32 2017 , Nr. 6 , S. 731 - 747, e1-e6DOI (Open Access)
-
Analysis of disseminated tumor cells before and after platinum based chemotherapy in primary ovarian cancer : Do stem cell like cells predict prognosis?In: OncoTarget , Jg. 7 2016 , Nr. 18 , S. 26454 - 26464DOI (Open Access)
-
Breast cancer-derived extracellular vesicles : clinical and prognostic impactIn: Cancer Research , Jg. 76 2016 , Nr. 14 Suppl. , S. 3152
-
Circulating tumor cells in triple-negative and non-triple negative breast cancer patients show different genetic profilesIn: Cancer Research , Jg. 76 2016 , Nr. 4 Suppl. , P2-02-05
-
Comparison of the HER2, estrogen and progesterone receptor expression profile of primary tumor, metastases and circulating tumor cells in metastatic breast cancer patientsIn: BMC Cancer , Jg. 16 2016 , Nr. 1 , S. 522DOI (Open Access)
-
Detection of circulating trophoblast particles in maternal blood using density gradient centrifugation in preeclampsia and in normotensive pregnanciesIn: Hypertension in Pregnancy , Jg. 35 2016 , Nr. 3 , S. 323 - 329
-
Different prognostic value of circulating and disseminated tumor cells in primary breast cancer : Influence of bisphosphonate intake?In: Scientific Reports , Jg. 6 2016 , S. 26355DOI (Open Access)
-
Do disseminated tumor cells with stem cell character after therapy predict prognosis in primary ovarian cancerIn: Cancer Research , Jg. 76 2016 , Nr. 14 Suppl. , S. 2492
-
Does primary neoadjuvant systemic therapy eradicate minimal residual disease? : Analysis of disseminated and circulating tumor cells before and after therapyIn: Breast Cancer Research , Jg. 18 2016 , 20DOI (Open Access)
-
Establishment of a multimarker qPCR panel for the molecular characterization of circulating tumor cells in blood samples of metastatic breast cancer patients during the course of palliative treatmentIn: OncoTarget , Jg. 7 2016 , Nr. 27 , S. 41677 - 41690DOI (Open Access)
-
Evaluation of a novel ELISA for the tumor-associated antigen CA 72-4 in patients with ovarian cancerIn: International Journal of Pharmacokinetics , Jg. 2 2016 , Nr. 4 , S. FSO145DOI (Open Access)
-
Gene expression signatures in circulating tumor cells are prognostic for metastatic lesions in breast cancer patients and correlate with response to therapyIn: Cancer Research , Jg. 76 2016 , Nr. 14 Suppl. , S. 502
-
In primary breast cancer patients with HER2-negative tumors, HER2-positive circulating tumor cells with stem cell character predict worse outcomeIn: Cancer Research , Jg. 76 2016 , Nr. 4 Suppl. , P2-02-01
-
Serum concentrations of soluble B7-H4 in early pregnancy are elevated in women with preterm premature rupture of fetal membranesIn: American Journal of Reproductive Immunology , Jg. 76 2016 , Nr. 2 , S. 149 - 154
-
The co-stimulatory soluble B7-H4 molecule is elevated in early pregnancy in women with premature rupture of fetal membranesIn: Journal of Reproductive Immunology , Jg. 115 2016 , S. 67
-
The presence and persistence of ERCC1 positive circulating tumor cells predicts worse prognosis in primary ovarian cancer patientsIn: Cancer Research , Jg. 76 2016 , Nr. 14 Suppl. , S. 447
-
The prognostic impact of soluble and vesicular HLA-G and its relationship to circulating tumor cells in neoadjuvant treated breast cancer patientsIn: Human Immunology , Jg. 77 2016 , Nr. 9 , S. 791 - 799
-
iSERS microscopy guided by wide field immunofluorescence : analysis of HER2 expression on normal and breast cancer FFPE tissue sectionsIn: The Analyst / Royal Society of Chemistry (RSC) (Hrsg.) , Jg. 141 2016 , Nr. 17 , S. 5113 - 5119DOI (Open Access)
-
Association between tumor infiltrating immune cells, circulating tumor cells in blood and disseminated tumor cells in the bone marrow in patients with primary ovarian cancerIn: Cancer Research , Jg. 75 2015 , Nr. 15 Suppl.
-
Change of anti-Mullerian-hormone levels during follicular phase in PCOS patientsIn: Gynecological Endocrinology , Jg. 31 2015 , Nr. 1 , S. 26 - 30
-
Changes in the Blood Serum Levels of the Costimulatory Soluble B7-H4 Molecule in Pregnant Women During the Peripartal PhaseIn: American Journal of Reproductive Immunology , Jg. 74 2015 , Nr. 3 , S. 209 - 215
-
Detection of disseminated tumor cells in bone marrow and circulating tumor cells in blood of patients with early-stage male breast cancerIn: Journal of Cancer Research and Clinical Oncology , Jg. 141 2015 , Nr. 1 , S. 87 - 92
-
Different prognostic value of circulating and disseminated tumor cells in primary breast cancer : Influence of bisphosphonate intake?In: Cancer Research , Jg. 75 2015 , Nr. 9 Suppl.
-
ERCC1-positive circulating tumor cells in the blood of ovarian cancer patients as a predictive biomarker for platinum-restistanceIn: International Journal of Gynecological Cancer , Jg. 25 2015 , Nr. 9 (Supplement 1) , S. 464
-
Evaluation of the prognostic significance of disseminated tumor cells in the bone marrow of primary, non-metastatic breast cancer patients after a 7-year follow-upIn: Archives of Gynecology and Obstetrics , Jg. 292 2015 , Nr. 5 , S. 1117 - 1125
-
Expression profiling of circulating tumor cells : A prognostic and predictive biomarker in metastatic breast cancerIn: Cancer Research , Jg. 75 2015 , Nr. 15 Suppl.
-
Influence of lifestyle factors and tumor cell dissemination in 632 early breast cancer patientsIn: Cancer Research , Jg. 75 2015 , Nr. 9 Suppl.
-
Maternal serum copeptin, MR-proANP and procalcitonin levels at 11–13 weeks gestation in the prediction of preeclampsiaIn: Archives of Gynecology and Obstetrics , Jg. 292 2015 , Nr. 5 , S. 1033 - 1042
-
Molecular characterization of circulating tumor cells allows stratifying for prognosis in breast cancer patients undergoing neoadjuvant therapyIn: Cancer Research , Jg. 75 2015 , Nr. 15 Suppl.
-
SOX17 gene promoter methylation in high-grade serous epithelial ovarian cancerIn: Cancer Research , Jg. 75 2015 , Nr. 15 Supplement
-
Single nucleotide polymorphisms of the EpCAM-coding gene TACSTD1 in patients with ovarian cancer and their potential translational aspectsIn: Archives of Gynecology and Obstetrics , Jg. 292 2015 , Nr. 6 , S. 1367 - 1372
-
The AdnaCellector, a new fully automated selection for circulating tumor cells in blood of primary and metastatic breast cancer patientsIn: Cancer Research , Jg. 75 2015 , Nr. 15 Suppl.
-
The prognostic impact of soluble HLA-G and its relationship to circulating tumor cells in neoadjuvant treated breast cancer patientsIn: Tissue Antigens , Jg. 86 2015 , Nr. 2 , S. 81
-
A fully automated q-PCR-based circulating tumor cell analysis using the Alere TM q-Analyzer test platformIn: Cancer Research , Jg. 74 2014 , Nr. Suppl. 19 , S. 3076
-
Anti-Mullerian Hormone : an indicator for the severity of polycystic ovarian syndromeIn: Archives of Gynecology and Obstetrics , Jg. 290 2014 , Nr. 5 , S. 1023 - 1030
-
Circulating U2 Small Nuclear RNA Fragments as a Novel Diagnostic Tool for Patients with Epithelial Ovarian CancerIn: Clinical Chemistry , Jg. 60 2014 , Nr. 1 , S. 206 - 213
-
Detection of disseminated tumor cells in the bone marrow and circulating tumor cells in blood of patients with early-stage male breast cancerIn: Journal of Clinical Oncology (JCO) , Jg. 32 2014 , Nr. 15 Suppl. , S. e22032
-
ERCC1-Positive Circulating Tumor Cells in the Blood of Ovarian Cancer Patients as a Predictive Biomarker for Platinum ResistanceIn: Clinical Chemistry , Jg. 60 2014 , Nr. 10 , S. 1282 - 1289
-
Establishment of a new method for the selection and detection of circulating tumor cells in metastatic breast cancer patientsIn: Cancer Research , Jg. 74 2014 , Nr. 19 Suppl.
-
Explorative investigation of vascular endothelial growth factor receptor expression in primary ovarian cancer and its clinical relevanceIn: Gynecologic Oncology , Jg. 133 2014 , Nr. 3 , S. 467 - 472
-
High throughput few and single cell expression profiling and the characterization of circulating tumor cellsIn: Anticancer Research , Jg. 34 2014 , Nr. 10 , S. 6014
-
Intraindividual right-left comparison of sonographic features in polycystic ovary syndrome (PCOS) diagnosisIn: European Journal of Obstetrics & Gynecology and Reproductive Biology , Jg. 181 2014 , S. 124 - 129
-
Predictive markers for the FSH sensitivity of women with polycystic ovarian syndromeIn: Human Reproduction , Jg. 29 2014 , Nr. 3 , S. 518 - 524
-
Serum concentrations of afamin are elevated in patients with polycystic ovary syndromeIn: Endocrine Connections , Jg. 3 2014 , Nr. 3 , S. 120 - 126DOI (Open Access)
-
Single nucleotide polymorphism of the EpCAM-coding gene TACSTD1 in patients with ovarian cancer and their potential implications in clinical practiceIn: Journal of Clinical Oncology (JCO) , Jg. 32 2014 , Nr. 15 Suppl. , S. e16515
-
Anti-Mullerian-hormone levels during pregnancy and postpartumIn: Reproductive Biology and Endocrinology , Jg. 11 2013 , Nr. 1 , 60
-
Clinical relevance of VEGF-receptor status in primary ovarian cancer : A pilot study for future biomarker analysesIn: Journal of Clinical Oncology (JCO) , Jg. 31 2013 , Nr. 15, Suppl. , S. 5556
-
Comparison of three molecular assays for the detection and molecular characterization of circulating tumor cells in breast cancerIn: Breast Cancer Research , Jg. 15 2013 , Nr. 2 , R20DOI (Open Access)
-
Establishment of a multimarker gene panel for the characterization of circulating tumor cells in metastatic breast cancerIn: Cancer Research , Jg. 73 2013 , Nr. 8 Suppl.
-
Evaluation and correlation of risk recurrence in early breast cancer assessed by Oncotype DX, clinicopathological markers and tumor cell dissemination in the blood and bone marrowIn: Molecular and Clinical Oncology , Jg. 1 2013 , Nr. 6 , S. 1049 - 1054
-
Evaluation of risk recurrence in early breast cancer assessed by Oncotype DX and tumor cell dissemination to blood and bone marrowIn: Journal of Clinical Oncology (JCO) , Jg. 31 2013 , Nr. Suppl. 15 , S. e11516
-
Pooled analysis of the prognostic relevance of disseminated tumor cells in the bone marrow of patients with ovarian cancerIn: International Journal of Gynecological Cancer , Jg. 23 2013 , Nr. 5 , S. 839 - 845
-
Serum mass spectrometry analysis in primary ovarian cancer (OC) treated with surgery and adjuvant chemotherapy (CT)In: Journal of Clinical Oncology (JCO) , Jg. 31 2013 , Nr. Suppl. 15
-
The persistence of ERCC1-positive circulating tumor cells predicts worse prognosis in patients with primary ovarian cancerIn: Cancer Research , Jg. 73 2013 , Nr. Suppl. 8
-
Utility of mesothelin, L1CAM and afamin as biomarkers in primary ovarian cancerIn: Anticancer Research , Jg. 33 2013 , Nr. 1 , S. 329 - 336
-
Validity of bone marker measurements for monitoring response to bisphosphonate therapy with zoledronic acid in metastatic breast cancerIn: Oncology Reports , Jg. 30 2013 , Nr. 1 , S. 441 - 447
-
Detection of disseminated tumor cells in bone marrow as an independent prognostic factor in primary ovarian cancer patientsIn: Journal of Clinical Oncology (JCO) , Jg. 30 2012 , Nr. 15, Suppl.
-
Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cellsIn: Breast Cancer Research , Jg. 14 2012 , Nr. 1 , R15DOI, Online Volltext (Open Access)
-
LOH at 6q and 10q in fractionated circulating DNA of ovarian cancer patients is predictive for tumor cell spread and overall survivalIn: BMC Cancer , Jg. 12 2012 , S. 325DOI, Online Volltext (Open Access)
-
MicroRNA and the pathogenesis of ovarian cancer – a new horizon for molecular diagnostics and treatment?In: Clinical Chemistry and Laboratory Medicine , Jg. 50 2012 , Nr. 4 , S. 601 - 615
-
Prognostic impact of circulating tumor cells assessed with the CellSearch System™ and AdnaTest Breast™ in metastatic breast cancer patients: The DETECT studyIn: Breast Cancer Research , Jg. 14 2012 , Nr. 4 , R118DOI (Open Access)
-
Schlafende Tumorzellen : Widerstandskämpfer der gynäkologischen TumorerkrankungenIn: Unikate: Berichte aus Forschung und Lehre 2012 , Nr. 42: Translationale Krebsforschung: Auf dem Weg zu neuen Therapien , S. 80 - 89DOI, Online Volltext (Open Access)
-
Serum HER2 in the context of circulating tumor cells in patients with metastatic breast cancerIn: Journal of Clinical Oncology (JCO) , Jg. 30 2012 , Nr. 15, Suppl. , S. 10599
-
Apoptosis-related deregulation of proteolytic activities and high serum levels of circulating nucleosomes and DNA in blood correlate with breast cancer progressionIn: BMC Cancer , Jg. 11 2011 , S. 4DOI (Open Access)
-
Circulating 20S proteasome in patients with non-metastasized breast cancerIn: Anticancer Research , Jg. 31 2011 , Nr. 6 , S. 2197 - 2201(Open Access)
-
Comparison of PIK3CA Hot Spot Mutations in the Primary Tumor or Metastases with PIK3CA Mutations or PIK3CA Over-Expression in Circulating Tumor Cells of Metastatic Breast Cancer Patients under Sequential Palliative TherapyIn: Cancer Research , Jg. 71 2011 , Nr. Suppl. 24
-
Comparison of estrogen and progesterone receptor status of circulating tumor cells and the primary tumor in metastatic breast cancer patientsIn: Gynecologic Oncology , Jg. 122 2011 , Nr. 2 , S. 356 - 360
-
Effect of ibandronate on disseminated tumor cells in the bone marrow of patients with primary breast cancer : A pilot studyIn: Anticancer Research , Jg. 31 2011 , Nr. 10 , S. 3623 - 3628
-
EpCAM-autoantibody levels in the course of disease of ovarian cancer patientsIn: Medical Oncology , Jg. 28 2011 , Nr. 2 , S. 626 - 630
-
Impact of platinum-based chemotherapy on circulating nucleic acid levels, protease activities in blood and disseminated tumor cells in bone marrow of ovarian cancer patientsIn: International Journal of Cancer , Jg. 128 2011 , Nr. 11 , S. 2572 - 2580DOI (Open Access)
-
Loss of heterozygosity proximal to the M6P/IGF2R locus is predictive for the presence of disseminated tumor cells in the bone marrow of ovarian cancer patients before and after chemotherapyIn: Genes, Chromosomes and Cancer , Jg. 50 2011 , Nr. 8 , S. 598 - 605
-
Molecular Profiling and Prognostic Relevance of Circulating Tumor Cells in the Blood of Ovarian Cancer Patients at Primary Diagnosis and After Platinum-Based ChemotherapyIn: International Journal of Gynecological Cancer , Jg. 21 2011 , Nr. 5 , S. 822 - 830
-
Prognostic Impact of Circulating Tumor Cells Assessed with the Cell Search Assay and Adna Test Breast in Metastatic Breast Cancer Patients – The DETECT StudyIn: Cancer Research , Jg. 71 2011 , Nr. 24
-
Prospective evaluation of serum tissue inhibitor of metalloproteinase 1 and carbonic anhydrase IX in correlation to circulating tumor cells in patients with metastatic breast cancerIn: Breast Cancer Research , Jg. 13 2011 , Nr. 4 , R71DOI (Open Access)
-
Screening for circulating nucleic acids and caspase activity in the peripheral blood as potential diagnostic tools in lung cancerIn: Molecular Oncology , Jg. 5 2011 , Nr. 3 , S. 281 - 291
-
The prognostic impact of circulating proteasome concentrations in patients with epithelial ovarian cancerIn: Gynecologic Oncology , Jg. 120 2011 , Nr. 2 , S. 233 - 238
-
Abstract P3-02-09: Expression of Stem Cell and Epithelial-Mesenchymal Transition Markers in Primary Breast Cancer Patients with Circulating Tumor CellsIn: Cancer Research , Jg. 70 2010 , Nr. 24 , S. P3 - 02
-
Abstract PD02-04: Molecular Profiling of Circulating Tumor Cells in Blood of Metastatic Breast Cancer Patients Indicates Therapy Response and Provides Information on Epithelial Mesenchymal Transition and Tumor Stem Cell MetabolismIn: Cancer Research , Jg. 70 2010 , Nr. 24 , S. PD02 - 04
-
Effect of ibandronate on tumor cells in the bone marrow and in blood in patients with primary breast cancer : A pilot study
IBMS Davos Workshops: Bone Biology & Therapeutics; 14-19 March 2010; Davos, Switzerland,In: Bone: Official Journal of the International Bone and Mineral Society (IBMS) , Jg. 46 2010 , Nr. Suppl. 1 , S. S38 -
Gene expression profiling in circulating cells (CTCS) of breast carcinoma patientsIn: Annals of Oncology , Jg. 21 2010 , S. 49 - 50
-
HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trialIn: Breast Cancer Research and Treatment , Jg. 124 2010 , Nr. 2 , S. 403 - 412
-
Impact of disseminated tumor cells in bone marrow on outcome of patients with primary ovarian cancerIn: Journal of Clinical Oncology (JCO) , Jg. 28 2010 , Nr. Suppl. 15 , S. e15545
-
Prospective evaluation of serum HER2 in comparison with HER2 expression on circulating tumor cells in metastatic breast cancer patients as part of the DETECT studyIn: Onkologie , Jg. 33 Suppl. 2 2010 , S. 19 - 19
-
Prospective evaluation of serum tissue inhibitor of metalloproteinase-1 (TIMP-1) and carbonic anhydrase IX (CAIX) in correlation to circulating tumor cells in patients with metastatic breast cancerIn: Journal of Clinical Oncology (JCO) , Jg. 28 2010 , Nr. Suppl. 15 , S. 1153 - 1153
-
The CYP1A1 Ile462Val polymorphism and platinum resistance of epithelial ovarian neoplasmsIn: Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics , Jg. 18 2010 , Nr. 7 , S. 343 - 347
-
Association of the AA genotype of the BCL2 (-938C>A) promoter polymorphism with better survival in ovarian cancerIn: The International Journal of Biological Markers (IJBM) , Jg. 24 2009 , Nr. 4 , S. 223 - 229
-
Comparative evaluation of cell-free tumor DNA in blood and disseminated tumor cells in bone marrow of patients with primary breast cancerIn: Breast Cancer Research , Jg. 11 2009 , Nr. 5 , R71DOI (Open Access)
-
The AA genotype of a L1C G842A polymorphism is associated with an increased risk for ovarian cancer.In: Anticancer Research , Jg. 29 2009 , Nr. 8 , S. 3449 - 3452
-
The haplotype of two FSHR polymorphisms in ovarian cancer : A potential role of ethnology in risk modificationIn: Gynecologic Oncology , Jg. 112 2009 , Nr. 3 , S. 486 - 489
-
Influence of platinum-based chemotherapy on disseminated tumor cells in blood and bone marrow of patients with ovarian cancerIn: Gynecologic Oncology , Jg. 107 2007 , Nr. 2 , S. 331 - 338
-
Rare expression of target antigens for immunotherapy on disseminated tumor cells in breast cancer patients without overt metastasesIn: International Journal of Molecular Medicine , Jg. 12 2003 , Nr. 6 , S. 969 - 975
-
Image-based identification of single circulating tumor cells in ovarian cancer patients for genomic analysis
AACR Annual Meeting 2021, April 10-15, 2021 and May 17-21, 2021, Philadelphia, PA, USA,In: Cancer Research , Jg. 81 2021 , Nr. Suppl. 13 , 594 -
Metastatic breast cancer subgroup specific mRNA profiles of circulating tumor cells and extracellular vesicles
AACR Annual Meeting 2020; April 27-28, 2020 and June 22-24, 2020; Philadelphia, USA,In: Cancer Research , Jg. 80 2020 , Nr. Suppl. 16 , S. 5366DOI (Open Access) -
Establishment of a workflow for analysis of mRNA and gDNA from circulating tumor cells, extracellular vesicles and cell-free DNA from the same blood sample to mirror the genomic and transcriptomic complexity in metastatic breast cancer patientsIn: Cancer Research , Jg. 79 2019 , Nr. Suppl. 13DOI (Open Access)
-
Workflow evaluation for molecular characterization of single circulating tumor cells in blood samples of patients with gynecological malignanciesIn: Cancer Research , Jg. 79 2019 , Nr. Suppl. 13DOI (Open Access)
-
Comparison of HER2, estrogen and progesterone receptor expression profiles of primary tumor, synchronous axillary lymph node metastases and circulating tumor cells in early breast cancer patients
2017 San Antonio Breast Cancer Symposium ; December 5-9, 2017, San Antonio, Texas,In: Cancer Research , Jg. 78 2018 , Nr. 4, Supplement , S. PD3 - 02DOI (Open Access) -
ESR1methylation in primary tumors and paired circulating tumor DNA of patients with high-grade serous ovarian cancerIn: Cancer Research , Jg. 78 2018 , Nr. Suppl. 13 , 4587DOI (Open Access)
-
Elevated serum RAS p21 is an independent prognostic factor in metastatic breast cancer
2017 San Antonio Breast Cancer Symposium ; December 5-9, 2017, San Antonio, Texas,In: Cancer Research , Jg. 78 2018 , Nr. 4, Supplement , P2-02-15DOI (Open Access) -
Overexpression of CXCR4 and JUNB in disseminated tumor cells (DTCs) isolated from breast cancer patients before neoadjuvant treatmentIn: Cancer Research , Jg. 78 2018 , Nr. Suppl. 13DOI (Open Access)
-
Serum levels of RANKL are increased in primary breast cancer patients in the presence of disseminated tumor cells in the bone marrow
2018 Annual Meeting of the American Society for Bone and Mineral Research Palais des congrès de Montréal in Montréal, Quebéc, Canada September 28 – October 1, 2018,In: Journal of Bone and Mineral Research (JBMR) , Jg. 33 2018 , Nr. Suppl. 1 , S. 72 - 73 -
Similarities and differences in RNA profiles of circulating tumor cells in breast cancer subtypes : Do we have therapeutic options?
2017 San Antonio Breast Cancer Symposium ; December 5-9, 2017, San Antonio, Texas,In: Cancer Research , Jg. 78 2018 , Nr. 4, Supplement , P2-01-06DOI (Open Access) -
Single HER2-positive tumor cells are detected in initially HER2-negative breast carcinomas using the DEPArray (TM)-HER2 FISH workflowIn: Cancer Research , Jg. 79 2018 , Nr. Suppl. 13 , 4530DOI (Open Access)
-
Use of unique molecular identifiers to gain insight about the true positive mutations in cfDNA of breast cancer patients for implementation of personalized treatmentIn: Cancer Research , Jg. 79 2018 , Nr. Suppl. 13DOI (Open Access)
-
ERCC1-Expressinf Circulating Tumor Cells as a Potential Diagnostic Tool for Monitoring Platinum-Based Chemotherapy and for Predicting Outcome of Ovarian CancerIn: International Journal of Gynecological Cancer , Jg. 27 2017 , Nr. Suppl. 4 , S. ESGO7 - 0140
-
Analysis of disseminated tumor cells before and after platinum-based chemotherapy in primary ovarian cancer : Do stem cell like cells predict prognosis?
Krebsmedizin heute: präventiv, personalisiert, präzise und partizipativ ; 32. Deutscher Krebskongress ; 24.-27. Februar 2016, Berlin,In: Oncology Research and Treatment , Jg. 39 2016 , Nr. Suppl. 1 , S. 22 -
Association between tumor infiltrating immune cells and disseminated tumor cells in the bone marrow of patients with primary breast cancer : A ten year follow-upIn: Cancer Research , Jg. 76 2016 , Nr. 4 Suppl. , P4-04-07
-
Circulating U2 small nuclear RNA fragments as a novel diagnostic tool for patients with epithelial ovarian cancer
Krebsmedizin heute: präventiv, personalisiert, präzise und partizipativ ; 32. Deutscher Krebskongress ; 24.-27. Februar 2016, Berlin,In: Oncology Research and Treatment , Jg. 39 2016 , Nr. Suppl. 1 , S. 95 - 96 -
The detection of excision repair cross-complementing rodent repair deficiency, complementation group 1-positive circulating tumor cells in the blood of ovarian cancer patients as a predictive biomarker for platinum-resistance
31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin,In: Oncology Research and Treatment , Jg. 37 2014 , Nr. Suppl. 1 , S. 3 -
Comparison of the HER2, estrogen and progesterone receptor expression profile of primary tumor, metastases and circulating tumor cells in metastatic breast cancer patientsIn: Cancer Research , Jg. 73 2013 , S. PD6 - 3
-
The role of excision repair cross-complementation 1 enzyme (ERCC1)-positive circulating tumor cells in primary and metastatic breast cancerIn: Cancer Research , Jg. 73 2013 , P1-04-13
-
MicroRNA-1246 as a novel candidate for a blood-based biomarker in ovarian cancer patientsIn: Cancer Research , Jg. 72 2012 , Nr. 8, Suppl. , S. 4132
-
Are mesothelin and L1CAM useful biomarkers in primary ovarian cancer patients?In: Journal of Clinical Oncology (JCO) , Jg. 29 2011 , Nr. 15, Suppl. , S. e15559
-
CK-19, MAGE-A3, HER-2 and TWIST-1 expression by RT-qPCR in CTCs of primary breast cancer patients after positive immune-magnetic selection using anti-EpCAM and anti-MUC1 magnetic beadsIn: Cancer Research , Jg. 71 2011 , Nr. 8, Suppl. , S. 4150
-
Primary tumor loss of heterozygosity proximal to M6P/IGF2R locus is predictive for the presence and persistence of disseminated tumor cells in the bone marrow of ovarian cancer patientsIn: Cancer Research , Jg. 71 2011 , Nr. 8, Suppl. , S. 2217
-
Are bisphosphonate ibandronate influence disseminated tumor cells in the bone marrow and circulating blood tumor cells in patients with primary breast cancers? Presentation of a pilot studyIn: Onkologie , Jg. 33 2010 , Nr. Suppl.2 , S. 38 - 38
-
Comparison of estrogen and Progesterone receptor expression on circulating Tumor cells and the Primary tumor in Patients with metastatic Breast cancer
29. Deutscher Krebskongress. Berlin 24.-27. Februar 2010,In: Onkologie , Jg. 33 2010 , Nr. Suppl. 2 , S. 212 -
Molecular Characterization of Single Circulating Tumor Cells in Breast and Ovarian CancerIn: Circulating Tumor Cells / Cote, Richard J.; Lianidou, Evi (Hrsg.) 2023 , S. 327 - 358
-
A clustering and mutual information based analysis of the ELIMA study results : The additive value of multi-parametric liquid biopsies, including CTCs, EVs and cfDNA, in metastatic breast cancer
San Antonio Breast Cancer Virtual Symposium; December 8-11, 2020; San Antonio, Texas,In: Cancer Research , Jg. 81 2021 , Nr. 4, Supplement , S. PS6 - 60DOI (Open Access) -
Dynamics of a multi-parametric liquid biopsy, including CTCs, EVs, and cfDNA, during therapy in metastatic breast cancer patients provide useful insights for therapy management
San Antonio Breast Cancer Virtual Symposium ; December 8-11, 2020; San Antonio, Texas,In: Cancer Research 2021 , S. PS2 - 24DOI (Open Access) -
Validity of Bone Marker Measurements for Monitoring Response to Bisphosphonate (BP) Therapy with Zoledronic Acid (ZOL) in Metastatic Breast Cancer (mBC) : Useful or Not?
Thirty-Third Annual CTRC‐AACR San Antonio Breast Cancer Symposium, Dec 8‐12, 2010, San Antonio, TX, USA,In: Cancer Research , Jg. 70 2010 , Nr. 24, Supplement , P2-09-33